It is also important to consider the effect of genetic and epigenetic differences between cancer patients, and the possible ways in which cancer cells may compensate for a depletion in one LOX family member by upregulation of other family members or mechanisms involved in collagen cross-linking. The gene discussed is LOX; the disease is cancer.